OPB-111077 / Otsuka  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
OPB-111077 / Otsuka
NCT03158324: Phase IIa Dose-Expansion and Biomarker Study of OPB-111077

Unknown status
2a
52
RoW
OPB-111077
National University Hospital, Singapore, Otsuka Pharmaceutical Co., Ltd.
NPC, Refractory Tumor
05/20
11/20

Download Options